Medical Xpress1d
Fibrosis lacks treatments and methods of reversal: Study pinpoints a promising target for drug therapy
Medical science has long been on the hunt for a deeper understanding of the devastating scarring of the body's organs known ...
healthcare-in-europe.com4d
Fibrosis a prognostic biomarker for HER2-negative breast cancer
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
Study confirms fibrosis as a prognostic indicator in the most common breast cancer
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
thorax.bmj14d
Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study
Background A usual interstitial pneumonia (UIP) pattern of lung injury is a key feature of idiopathic pulmonary fibrosis (IPF) and is also observed in up to 40% of individuals with rheumatoid ...
Pharmaceutical Technology15d
Garadacimab by CSL for Idiopathic Pulmonary Fibrosis: Likelihood of Approval
Garadacimab is under clinical development by CSL and currently in Phase II for Idiopathic Pulmonary Fibrosis. According to GlobalData, Phase II drugs for Idiopathic Pulmonary Fibrosis have a 35% phase ...
Frontiers17d
Role of telomere dysfunction and immune infiltration in idiopathic pulmonary fibrosis: new insights from bioinformatics analysis
BackgroundIdiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease characterized by unexplained ...
Frontiers26d
Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?
Nintedanib, effective in idiopathic pulmonary fibrosis ... current diagnostic and therapeutic approaches. Extracellular matrix collagen, which starts during granuloma formation, states that fibrosis ...